{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T22:24:51Z","timestamp":1759616691632},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1-3","license":[{"start":{"date-parts":[[1995,8,1]],"date-time":"1995-08-01T00:00:00Z","timestamp":807235200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[1995,8]]},"DOI":"10.1007\/bf02740681","type":"journal-article","created":{"date-parts":[[2007,11,7]],"date-time":"2007-11-07T12:49:52Z","timestamp":1194439792000},"page":"21-29","source":"Crossref","is-referenced-by-count":21,"title":["Catecholamine and MHPG plasma levels, platelet MAO activity, and3H-imipramine binding in heroin and cocaine addicts"],"prefix":"10.1007","volume":"11","author":[{"given":"T.","family":"Macedo","sequence":"first","affiliation":[]},{"given":"C. A.","family":"Fontes Ribeiro","sequence":"additional","affiliation":[]},{"given":"D.","family":"Cotrim","sequence":"additional","affiliation":[]},{"given":"P.","family":"Tavares","sequence":"additional","affiliation":[]},{"given":"M. T.","family":"Morgadinho","sequence":"additional","affiliation":[]},{"given":"M.","family":"Caramona","sequence":"additional","affiliation":[]},{"given":"M. T.","family":"Nunes Vicente","sequence":"additional","affiliation":[]},{"given":"L.","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"M. G.","family":"Cardoso","sequence":"additional","affiliation":[]},{"given":"M. L.","family":"Keating","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BF02740681_CR1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2265.1986.tb03273.x","volume":"24","author":"P. M. G. Bouloux","year":"1986","unstructured":"Bouloux P. M. G., Grossman A. B., and Besser G. M. (1986) Naloxone provokes catecholamine release in phaeochromocytomas and paragangliomas.Clin. Endocrinol. 24, 319\u2013325.","journal-title":"Clin. Endocrinol."},{"key":"BF02740681_CR2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1126\/science.7384806","volume":"209","author":"M. S. Briley","year":"1980","unstructured":"Briley M. S., Langer S. Z., Raisman R., Secleter D., and Zarifan E. (1980) Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients.Science 209, 303\u2013305.","journal-title":"Science"},{"key":"BF02740681_CR3","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0014-2999(85)90573-4","volume":"110","author":"N. Brunello","year":"1985","unstructured":"Brunello N., Riva M., Volterra A., and Racagni G. (1985) Age-related changes in 5-HT uptake and [3H]-impiramine binding sites in rat cerebral cortex.Eur. J. Pharmacol. 110, 393\u2013394.","journal-title":"Eur. J. Pharmacol."},{"key":"BF02740681_CR4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/1056-8719(92)90075-C","volume":"28","author":"J. N. Buchholz","year":"1992","unstructured":"Buchholz J. N. and Duckles S. P. (1992) In vitro measurement of endogenous norepinephrine release from small blood vessels with short stimulation trains.J. Pharmacol. Toxicol. Methods 28, 137\u2013141.","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"Suppl.","key":"BF02740681_CR5","first-page":"161","volume":"32","author":"M. M. Caramona","year":"1990","unstructured":"Caramona M. M., Cotrim M. D., Fontes Ribeiro C. A., and Macedo T. (1990) Monoamine oxidase activity in blood platelets of migraine patients.J. Neurol. Transm. (Suppl.)32, 161\u2013164.","journal-title":"J. Neurol. Transm."},{"key":"BF02740681_CR6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0024-3205(83)90501-5","volume":"33","author":"E. Castanas","year":"1983","unstructured":"Castanas E., Giraud Y., Audigier Y., Drissi R., Boudouresque F., Conte-Devol B., and Olivier C. (1983) Opiate binding sites spectrum on bovine adrenal medullas and six human phaechromocytomas.Life Sci. 33, 295\u2013298.","journal-title":"Life Sci."},{"key":"BF02740681_CR7","first-page":"751","volume":"15","author":"C. Chavkin","year":"1979","unstructured":"Chavkin C., Cox B. M., and Goldstein A. (1979) Stereospecific opiate binding in bovine adrenal medulla.Mol. Pharmacol. 15, 751\u2013753.","journal-title":"Mol. Pharmacol."},{"key":"BF02740681_CR8","first-page":"97","volume-title":"Scatchard plot, inDose-Effect Analysis with Microcomputers","author":"Y. Chou","year":"1985","unstructured":"Chou Y. and Chou T.-Ch. (1985) Scatchard plot, inDose-Effect Analysis with Microcomputers (Chou Y. and Chou T.-Ch., eds.), Elsevier-Biosoft, Amsterdam, pp. 97\u2013102."},{"key":"BF02740681_CR9","first-page":"2946","volume":"42","author":"E. Costa","year":"1983","unstructured":"Costa E., Guidotti A., Hanbaner K., and Saiaini L. (1983) Modulation of nicotinic receptor function by opiate recognition sites highly selective for met 5-enkephalin.Fed. Proc. 42, 2946\u20132952.","journal-title":"Fed. Proc."},{"key":"BF02740681_CR10","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/0006-2952(79)90611-7","volume":"28","author":"E. M. Demet","year":"1979","unstructured":"Demet E. M. and Halaris A. E. (1979) Origin and distribution of 3-methoxy-4-hydroxyphenyl-glycol in body fluids.Biochem. Pharmacol. 28, 3043\u20133050.","journal-title":"Biochem. Pharmacol."},{"key":"BF02740681_CR11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/BF00405254","volume":"16","author":"G. A. Deneau","year":"1969","unstructured":"Deneau G. A., Yanagita T., and Seever M. H. (1969). Self-administration of psychoactive substances by the monkey.Psychopharmacology 16, 30\u201348.","journal-title":"Psychopharmacology"},{"key":"BF02740681_CR12","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","volume":"85","author":"G. Chiara Di","year":"1988","unstructured":"Di Chiara G. and Imperato A. (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system.Proc. Natl. Acad. Sci. USA 85, 5274\u20135278.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF02740681_CR13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0165-6147(92)90062-B","volume":"13","author":"G. Chiara Di","year":"1992","unstructured":"Di Chiara G. and North R. A. (1992) Neurobiology of opiate abuse.Trends Pharmacol. Sci. 13, 185\u2013193.","journal-title":"Trends Pharmacol. Sci."},{"key":"BF02740681_CR14","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1016\/0006-2952(79)90614-2","volume":"28","author":"C. J. Fowler","year":"1979","unstructured":"Fowler C. J., Ekstedt B., Egashira T., Kinemuchi H., and Oreland L. (1979) The interaction between human platelet monoamine oxidase, its monoamine substrates and oxygen.Biochem. Pharmacol. 28, 3063\u20133068.","journal-title":"Biochem. Pharmacol."},{"key":"BF02740681_CR15","doi-asserted-by":"crossref","first-page":"S598","DOI":"10.1097\/00005344-198406004-00006","volume":"6","author":"D. Ganten","year":"1984","unstructured":"Ganten D., Lang R. E., Archelos J., and Unger T. (1984) Peptidergic systems: effects on blood vessels.J. Cardiovasc. Pharmacol. 6, S598-S607.","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"BF02740681_CR16","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/0024-3205(76)90145-4","volume":"18","author":"R. E. Garey","year":"1976","unstructured":"Garey R. E. and Heath R. G. (1976) The effect of phencyclidine on the uptake of3H-catecholamines by rat striatal and hypothalamic synaptosomes.Life Sci. 18, 1105\u20131110.","journal-title":"Life Sci."},{"key":"BF02740681_CR17","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/01.HYP.5.4.552","volume":"5","author":"D. S. Goldstein","year":"1983","unstructured":"Goldstein D. S., McCarty R., Polinsky R. J., and Kopin I. J. (1983) Relationship between plasma norepinephrine and sympathetic neural activity.Hypertension 5, 552\u2013559.","journal-title":"Hypertension"},{"key":"BF02740681_CR18","first-page":"307","volume-title":"Clinical Endocrinology and Metabolism, vol. 7 (Catecholamines)","author":"P. Hjemdahl","year":"1993","unstructured":"Hjemdahl P. (1993) Plasma catecholamines\u2014analytical challenges and physiological limitations, inClinical Endocrinology and Metabolism, vol. 7 (Catecholamines) (Bouloux P.-M. G., ed.), Bailli\u00e8re Tindall, London, pp. 307\u2013353."},{"key":"BF02740681_CR19","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1523\/JNEUROSCI.04-04-00966.1984","volume":"4","author":"A. Imperato","year":"1984","unstructured":"Imperato A. and Di Chiara G. (1984) Trans-striatal dialysis coupled to reverse phase high-performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites.J. Neurosci. 4, 966\u2013977.","journal-title":"J. Neurosci."},{"key":"BF02740681_CR20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0165-6147(92)90060-J","volume":"13","author":"G. F. Koob","year":"1992","unstructured":"Koob G. F. (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways.Trends Pharmacol. Sci. 13, 177\u2013184.","journal-title":"Trends Pharmacol. Sci."},{"key":"BF02740681_CR21","first-page":"333","volume":"37","author":"I. J. Kopin","year":"1985","unstructured":"Kopin I. J. (1985) Catecholamine metabolism: basic aspects and clinical significance.Pharmacol. Rev. 37, 333\u2013364.","journal-title":"Pharmacol. Rev."},{"key":"BF02740681_CR22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/283489a0","volume":"283","author":"K. Kumakara","year":"1980","unstructured":"Kumakara K., Karoum A., Guidotti A., and Costa E. (1980) Modulation of nicotinic receptors by opiate receptor agonists in cultured adrenal chromaffin cells.Nature 283, 489\u2013492.","journal-title":"Nature"},{"key":"BF02740681_CR23","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/0024-3205(76)90210-1","volume":"18","author":"C. R. Lake","year":"1976","unstructured":"Lake C. R., Ziegler M. G., and Kopin J. J. (1976) Use of plasma norepinephrine for evaluation of sympathetic neuronal function in man.Life Sci. 18, 1315\u20131325.","journal-title":"Life Sci."},{"key":"BF02740681_CR24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/B978-0-12-232350-8.50011-X","volume-title":"Vascular Innervation and Receptor Mechanisms: New Perspectives","author":"P. Linton-Dahlof","year":"1993","unstructured":"Linton-Dahlof P. and Dahlof C. (1993) Norepinephrine and neuropeptide Y in the sympathetic system: prejunctional interactions and regulation of release, inVascular Innervation and Receptor Mechanisms: New Perspectives (Edvinsson L. and Uddman R., eds.), Academic, San Diego, CA, pp. 159\u2013173."},{"key":"BF02740681_CR25","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1523\/JNEUROSCI.10-11-03627.1990","volume":"10","author":"M. D. Loose","year":"1990","unstructured":"Loose M. D., Ronnekleim O. K., and Kelly M. J. (1990) Membrane properties and response to opioids of identified dopamine neurons in the guinea pig hypothalamus.J. Neurosci. 10, 3627\u20133634.","journal-title":"J. Neurosci."},{"key":"BF02740681_CR26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"O. H. Lowry","year":"1951","unstructured":"Lowry O. H., Rosenbrough N. J., Farr A. L., and Randell R. J. (1951) Protein measurement with the Folin phenol reagent.J. Biol. Chem. 193, 265\u2013275.","journal-title":"J. Biol. Chem."},{"issue":"2","key":"BF02740681_CR27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00002826-198704000-00008","volume":"10","author":"G. Magni","year":"1987","unstructured":"Magni G., Andreoli F., Arduino C., Argie D., Cecaherelli F., Ambrosio F., and Eandi M. (1987) [3H]-imipramine binding sites are decreased in platelets of chronic pain patients.Clin. Neuropharmacol. 10(2), 175\u2013177.","journal-title":"Clin. Neuropharmacol."},{"key":"BF02740681_CR28","first-page":"564","volume":"308","author":"M. Mannelli","year":"1983","unstructured":"Mannelli M., Maggi M., De Feo M. L., Cuomo S., Forti G., Moroni F., and Guisti G. (1983) Naloxone administration releases catecholamines.New Engl. J. Med. 308, 564\u2013565.","journal-title":"New Engl. J. Med."},{"key":"BF02740681_CR29","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0014-2999(83)90321-7","volume":"96","author":"E. T. Mellerup","year":"1983","unstructured":"Mellerup E. T., Plenge T. P., and Engelstof M. (1983) High affinity binding of3H-imipramine to human platelet membranes.Eur. J. Pharmacol. 96, 303\u2013309.","journal-title":"Eur. J. Pharmacol."},{"key":"BF02740681_CR30","first-page":"430","volume-title":"Bailli\u00e8re\u2019s Clinical Endocrinology and Metabolism Vol. 7: Catecholamines","author":"K. Shimizu","year":"1993","unstructured":"Shimizu K. and McGrath B. P. (1993) Sympathetic dysfunction in heart failure, inBailli\u00e8re\u2019s Clinical Endocrinology and Metabolism Vol. 7: Catecholamines (Bouloux P.-M. G., ed.), Bailliere Tindall, London, pp. 430\u2013463."},{"key":"BF02740681_CR31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.7326\/0003-4819-107-1-13","volume":"107","author":"H. W. Smith","year":"1987","unstructured":"Smith H. W., Liberman H. A., Brody S. L., Battey L. L., Donohone B. C., and Morris D. C. (1987) Acute myocardial infarction temporally related to cocaine use.Ann. Int. Med. 107, 13\u201318.","journal-title":"Ann. Int. Med."},{"key":"BF02740681_CR32","first-page":"118","volume":"205","author":"M. S. Stahl","year":"1977","unstructured":"Stahl M. S. and Meltzer H. Y. (1977) A kinetic and pharmacologic analysis of 5-hydroytryptamine transport by human platelets and platelet storage granules: comparision with central serotonergic neurones.J. Pharmacol. Exp. Ther. 205, 118\u2013205.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF02740681_CR33","first-page":"292","volume-title":"Central Serotonin Receptors and Psychotropic Drugs","author":"M. B. Tyres","year":"1992","unstructured":"Tyres M. B. and Hayes A. G. (1992) 5-HT receptors and addiction, inCentral Serotonin Receptors and Psychotropic Drugs (Marsden C. A. and Heal D. J., eds.), Blackwell Scientific, Oxford, pp. 292\u2013305."},{"key":"BF02740681_CR34","first-page":"669","volume":"223","author":"T. W. Vickroy","year":"1982","unstructured":"Vickroy T. W. and Johnson K. M. (1982) Similar dopamine-releasing effects of phencyclidine and noramphetamine stimulants in striatal slices.J. Pharmacol. Exp. Ther. 223, 669\u2013674.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF02740681_CR35","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0014-2999(84)90726-X","volume":"106","author":"M. A. Wilson","year":"1985","unstructured":"Wilson M. A. and Roy E. J. (1985) Age alters the observed response of imipramine binding sites to chronic antidepressant treatment in female rats.Eur. J. Pharmacol. 106, 381\u2013391.","journal-title":"Eur. J. Pharmacol."},{"key":"BF02740681_CR36","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1471-4159.1983.tb00893.x","volume":"41","author":"T. Zetterstrom","year":"1983","unstructured":"Zetterstrom T., Sharp T., Marsden C. A., and Ungerstedt U. (1983) In vivo measurement of dopamine and its metabolites by intracerebral dialysis: changes after D-amphetamine.J. Neurochem. 41, 1769\u20131773.","journal-title":"J. Neurochem."},{"key":"BF02740681_CR37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0014-2999(83)90614-3","volume":"89","author":"G. Zsilla","year":"1983","unstructured":"Zsilla G., Barbaccia M. L., Gaudolf O., Knoll J., and Costa E. (1983) (\u2212) Deprenil, a selective MAO \u201cB\u201d inhibitor, increases [3H]-imipramine binding and decreases \u03b2-adrenergic receptor function.Eur. J. Pharmacol. 89, 111\u2013117.","journal-title":"Eur. J. Pharmacol."}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02740681.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02740681\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02740681","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:29:26Z","timestamp":1630024166000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02740681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,8]]},"references-count":37,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[1995,8]]}},"alternative-id":["BF02740681"],"URL":"https:\/\/doi.org\/10.1007\/bf02740681","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,8]]}}}